STOCK TITAN

Daré Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Daré Bioscience (NASDAQ:DARE) announced that CEO Sabrina Martucci Johnson will participate in a Virtual Investor Closing Bell event on July 14, 2026, at 4:00 PM ET.

The live webcast and 90-day replay will be available on the company’s investor relations website.

Loading...
Loading translation...
Argus Jul 9 session
+1.97% close to close 0.8x rel. volume Open Argus
Details

News Market Reaction – DARE

On Jul 9, the day this news came out, DARE closed 1.97% above the previous close.

Data tracked by StockTitan Argus for the Jul 9 session.

Key Figures

Event date: July 14, 2026 Event time: 4:00 PM ET Replay availability: 90 days +1 more
Event date
July 14, 2026
Virtual Investor Closing Bell webcast
Event time
4:00 PM ET
Virtual Investor Closing Bell webcast start time
Replay availability
90 days
Webcast replay accessible on company website
Replay delay
2 hours
Approximate time after live event until replay is available

Historical Context

5 past events · Latest: Jul 01
5 events
  1. Jul 01

    product launch update

    24h Move
    +0.0%

    Announced Flora Sync LF5™ is available via direct-to-consumer platform.

  2. Jun 25

    launch preview

    24h Move
    -3.9%

    CEO discussed upcoming commercial launch and revenue opportunity for Flora Sync LF5™.

  3. Jun 18

    conference participation

    24h Move
    +4.3%

    Planned multiple leadership and innovation presentations at BIO International 2026.

  4. Jun 04

    product launch plan

    24h Move
    +6.3%

    Outlined upcoming Flora Sync LF5™ U.S. launch and first direct consumer revenue.

  5. May 26

    non-dilutive funding

    24h Move
    -1.3%

    Received additional NIH SBIR funding tranche to advance DARE-HPV program.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Live video webcast on Tuesday, July 14th, at 4:00 PM ET
Register here

SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that it will participate in a Virtual Investor Closing Bell event on Tuesday, July 14, 2026, at 4:00 PM ET.

For the segment, Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience, will provide a brief corporate overview highlighting the recent launch of FloraSync LF5™, the Company's strategy for thoughtfully building its commercial business while advancing its differentiated women's health pipeline, and the milestones that will shape Daré's long-term growth. The discussion will also provide insight into the Company's disciplined approach to capital allocation, commercialization, and execution as it works to create sustainable value for shareholders.

Additionally, there will be a live question and answer session with audience participants. Ms. Martucci Johnson will answer as many questions as possible in the time allowed.

A live video webcast will be available on the Presentations, Events & Webcasts page of the Investors section of the Company’s website (darebioscience.com). A webcast replay will become available approximately two hours following the live event and will be accessible in the same section of the Company’s website for 90 days.

ABOUT DARÉ BIOSCIENCE, INC.

Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré is working to change that. Learn more at darebioscience.com.

Contact:
Daré Bioscience Investor Relations
innovations@darebioscience.com
Source: Daré Bioscience, Inc.


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the Daré Bioscience (NASDAQ:DARE) Virtual Investor Closing Bell event?

The Daré Bioscience Virtual Investor Closing Bell event is scheduled for July 14, 2026, at 4:00 PM ET. According to Daré Bioscience, investors can watch via live video webcast on the Presentations, Events & Webcasts page of its investor website.

How can investors watch the Daré Bioscience (DARE) Virtual Investor Closing Bell webcast?

Investors can watch the Daré Bioscience Virtual Investor Closing Bell event through a live video webcast on the company’s investor website. According to Daré Bioscience, access is available on the Presentations, Events & Webcasts page, with a replay posted about two hours later.

What topics will Daré Bioscience (DARE) cover during the July 14, 2026 investor event?

Daré Bioscience will provide a corporate overview, discuss the FloraSync LF5 launch, and outline its commercial strategy. According to Daré Bioscience, the CEO will also review pipeline milestones, capital allocation, commercialization approach, execution focus, and answer live audience questions as time permits.

Will there be a replay of the Daré Bioscience (DARE) Virtual Investor Closing Bell event?

Yes, a replay will be available. According to Daré Bioscience, the webcast replay will be posted about two hours after the live event and remain accessible for 90 days on the Presentations, Events & Webcasts page of the investor website.

Who will present for Daré Bioscience (DARE) at the Virtual Investor Closing Bell event?

Sabrina Martucci Johnson, President and CEO of Daré Bioscience, will present at the event. According to Daré Bioscience, she will deliver a corporate overview, highlight FloraSync LF5, discuss growth strategy, and participate in a live question-and-answer session with investors.

Keep reading